Health Care

The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other experimental treatments.

Trump's FDA pick, Marty Makary, appears to be quelling fears about a major disruption to biotech and pharma. Neuralink approved for new studies, company says.

President-elect Donald Trump's agenda carries risks and rewards for various investment sectors, market experts said.

More than two million babies died in the first 20 days of their lives in 2022, and a startup, Biorithm, hopes to help prevent this with its monitoring device.

President-elect Donald Trump's return to the White House is poised to have big impacts on consumer health care.

Eli Lilly’s cholesterol pill impressed in a mid-stage trial. Meanwhile, Dexcom invested $75 million in Oura.

The complaint is the latest move in a bitter legal fight between the U.S.'s three largest so-called pharmacy benefit managers, or PBMs, and the FTC.

Trump's selection is sounding the alarm in the public health community and leaving the biotech and pharmaceutical industries cautious of changes to come. 

Henry Schein shares tracked for their best day since 2022 on Monday.

The health care sector has been the big loser in the market since the election.